January 2026
Create an account to continue using Similarweb
View website metrics, keywords, top marketing channels, market research tools, and more.
Create your free accountgeneonline.com
Global Rank
#708,049
63,549Showing Similarweb estimated data.
Publicly validate your site’s metrics by connecting your GA4
Reflect your success
Verify your website's traffic and engagement metrics by connecting to Google Analytics
Bounce Rate
51.64%
Pages per Visit
1.37
Avg Visit Duration
00:00:20
- Company
- - -
- Industry
- - -
Top 10 geneonline.com Competitors
The Top 10 Sites Like geneonline.com in January 2026 are ranked by their affinity to geneonline.com in terms of keyword traffic, audience targeting, and market overlap
precision medicine online provides the latest news for healthcare leaders and scientists interested in precision medicine and individualized approaches to treatment and prevention.
- Company
- - -
- Industry
- - -
Global Rank
#1,375,745
133,068Bounce Rate
43.92%
Pages per Visit
1.58
Avg Visit Duration
00:00:19
Similarity Score
100%Get the latest biopharma news, clinical trial updates, and industry insights at PipelineReview.com. Discover innovative therapies and regulatory news.
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
100%The opioid crisis may not be front and center anymore, but it’s raging still. A major problem is that overdose-reversal drugs don’t last long enough to help users who opt out of hospital treatment after they are revived. Elysium Therapeutics Inc. CEO Greg Sturmer talks with Randy Osborne about his firm’s candidate for a solution to the medical and societal problem. The NIH – which has been helpful to Elysium since the company’s founding – the FDA, and others are working to advance a longer-lasting reversal agent. Experiments already done with approved reversers, as well as computer modeling that’s been used by regulators previously, will help in the push, Sturmer said. Download transcript
- Company
- - -
- Industry
- - -
Global Rank
#311,180
76,202Country Rank
#36,779
20,067Bounce Rate
46.36%
Pages per Visit
1.61
Avg Visit Duration
00:00:29
Similarity Score
97%Fill in the form to subscribe to our newsletter. Please tell us a bit more about yourself so we can ensure the information we send you is relevant.
- Company
- - -
- Industry
- - -
Global Rank
#393,394
58,491Bounce Rate
57.74%
Pages per Visit
1.32
Avg Visit Duration
00:00:20
Similarity Score
96%In this webinar, experts from IQVIA Biotech and IQVIA will focus on enhancing site and country trial conduct by putting the patient at the heart of their studies. Explore solutions to the challenges faced in recruiting and retaining diverse patient populations and see how insights are operationalized to meet patient accessibility goals. Three key take-aways The importance of patient voice: Learn how integrating patient perspectives can improve trial outcomes and support an innovative patient-centric culture. Highlight innovative engagement strategies: Discover successful approaches to recruit and engage participants and the strategic support that fosters effective workflows among sponsors, sites and patients. Enhancing trial success through design and execution: Gain insights on clinical trial country prioritization and rethink your strategy, operations and delivery model to enhance diversity and trial success. We look forward to your participation! Speakers: Erin Finot, MS, MBA – Vice President, Immuno-Oncology and CAGT, IQVIA Biotech Katie Shaw – Senior Director, Patient & Site Networks, IQVIA Dawn Muscolino – Director, Strategic Site Solutions, IQVIA
- Company
- IQVIA Biotech
Global Rank
#2,558,852
871,714Bounce Rate
41.49%
Pages per Visit
1.63
Avg Visit Duration
00:00:19
Similarity Score
95%MedWatch is a business media covering the pharmaceutical and medtech industries. MedWatch reports on strategy, results, ambitions, successes, failures and much more.
- Company
- - -
- Industry
- - -
Global Rank
#920,565
64,334Bounce Rate
49.08%
Pages per Visit
1.46
Avg Visit Duration
00:00:29
Similarity Score
94%The latest clinical trial news for biotech and biopharmaceutical professionals
- Company
- BioPharma Dive
Global Rank
#196,688
11,940Bounce Rate
62.24%
Pages per Visit
1.72
Avg Visit Duration
00:00:56
Similarity Score
94%Delaware court rules Apple Tree Partners to receive $97M from Rigmora, owned by Russian billionaire Dimitry Rybolovlev, ensuring continued funding for biotech portfolio companies.
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
49.55%
Pages per Visit
2.19
Avg Visit Duration
00:02:11
Similarity Score
92%Publicis Health’s global CEO Matt McNally joins us to talk about how his return to Publicis Health has gone and what he makes of the new-look Omnicom.
- Company
- - -
- Industry
- - -
Global Rank
#392,799
11,976Bounce Rate
52.63%
Pages per Visit
1.44
Avg Visit Duration
00:00:29
Similarity Score
90%Contact UsSecond Floor, H-65, Sector 63Noida, Uttar Pradesh, India – 201301Please use the form to send us news topics, stories, comments, critiques, advertisi
- Company
- - -
- Industry
- - -
Global Rank
#2,147,167
217,123Bounce Rate
48.56%
Pages per Visit
1.47
Avg Visit Duration
00:00:12
Similarity Score
90%geneonline.com's top 5 competitors in January 2026 are: precisionmedicineonline.com, pipelinereview.com, bioworld.com, pharmaphorum.com, and more.
According to Similarweb data of monthly visits, geneonline.com’s top competitor in January 2026 is precisionmedicineonline.com. geneonline.com 2nd most similar site is pipelinereview.com, and closing off the top 3 is bioworld.com.
pharmaphorum.com ranks as the 4th most similar website to geneonline.com and iqviabiotech.com ranks fifth in January 2026.
The other five competitors in the top 10 list are medwatch.com, biopharmadive.com, endpoints.news, mmm-online.com, and pharmashots.com.